Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2025-12-25 @ 11:31 PM
Study NCT ID:
NCT05172193
Status:
UNKNOWN
Last Update Posted:
2022-09-08
First Post:
2021-12-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)
Sponsor:
PT. Kimia Farma (Persero) Tbk
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-31
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-23
First Submit QC Date:
None
Study First Post Date:
2021-12-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-04
Last Update Post Date:
2022-09-08
Last Update Post Date Type:
ACTUAL